LEPROSY: A FORGOTTEN PAST OR AN AI-GUIDED FUTURE? | Dermatovenereology and aesthetic medicine

LEPROSY: A FORGOTTEN PAST OR AN AI-GUIDED FUTURE?

Digital Object Identifier (DOI) https://doi.org/10.67620/dermajournal.1730061
E. M. Khodjaeva.1 , N. N. Malikova2
Received Sep 26, 2026
Revised Oct 11, 2026
Published Oct 16, 2026

Annotatsiya

Leprosy (Hansen’s disease) is curable, yet 172,717 new cases were reported worldwide in 2024, 72% in South-East Asia (WHO, 2025). As nerve damage is often permanent, WHO uses grade 2 disability (G2D) as a marker of delayed detection. Reviews report median diagnostic delays of 12–36 months and G2D shares of 5.6 – 43.2%, often due to limited knowledge and misdiagnosis (Dharmawan et al., 2021; 2022). Karakalpakstan - Central Asia’s historical endemic focus, with a leprosarium since 1933, now reports 95.5% of registered cases in northern districts (Eshboev & Utepbergenova, 2026).

Kalit so'zlar

—

Maqolaga iqtibos keltirish andozasi

APA style
E. M. Khodjaeva. (2026). LEPROSY: A FORGOTTEN PAST OR AN AI-GUIDED FUTURE?. *Dermatovenereology and aesthetic medicine*, 17(3), 93. https://doi.org/10.67620/dermajournal.1730061